Christophe Van Vaeck

GIMV health & care

Christophe Van Vaeck works within Gimv’s Health & Care platform since 9 years, where he gained broad experience ranging from early biotech, diagnostic and medtech companies up to mature private clinics. After the recent successful exit of Multiplicom, he is currently still a board member at Almaviva, Spineart and Agrosavfe. Before joining Gimv, Christophe was a financial analyst Life Sciences at Bank Degroof and KBC Securities, where he guided the Euronext IPOs of Galapagos, deVGen, Thrombogenics and Ablynx. Christophe earned his PhD in Molecular Cell Biology at K.U. Leuven, Belgium, in 2000.

 
IC

Investor
Pitch session


Wednesday April 5th from 09:00 am to 11:00 am
Investor Room

IC

Investor
Pitch session


Wednesday April 5th from 02:30 pm to 04:30 pm
Investor Room

 
IC

Investor
Pitch session


Thursday April 6th from 09:00 am to 11:30 am
Investor Room

IC

Investor
Pitch session


Thursday April 6th from 02:00 pm to 03:30 pm
Investor Room